George W. Hebard III

2012

In 2012, George W. Hebard III earned a total compensation of $514.5K as Interim Principal Executive Officer, Interim Chief Operating Officer and Secretary at Enzon Pharmaceuticals.

Compensation breakdown

Option Awards$131,602
Salary$226,365
Stock Awards$151,410
Other$5,127
Total$514,504
44.00%

Hebard received $226.4K in salary, accounting for 44% of the total pay in 2012.

Hebard also received $131.6K in option awards, $151.4K in stock awards and $5.1K in other compensation.

Rankings

In 2012, George W. Hebard III's compensation ranked 8,678th out of 11,487 executives tracked by ExecPay. In other words, Hebard earned more than 24.5% of executives.

ClassificationRankingPercentile
All
8,678
out of 11,487
25th
Division
Manufacturing
3,157
out of 4,253
26th
Major group
Chemicals And Allied Products
847
out of 1,198
29th
Industry group
Drugs
620
out of 920
33rd
Industry
Biological Products, Except Diagnostic Substances
103
out of 160
36th
Source: SEC filing on April 16, 2014.

Hebard's colleagues

We found five more compensation records of executives who worked with George W. Hebard III at Enzon Pharmaceuticals in 2012.

2012

Ana Stancic

Enzon Pharmaceuticals

Chief Financial Officer

2012

Andrew Rackear

Enzon Pharmaceuticals

General Counsel

2012

Charles Conover

Enzon Pharmaceuticals

Former Senior Vice President of Research & Development, Program Management

2012

Aby Buchbinder

Enzon Pharmaceuticals

Former Vice President, Clinical Development

2012

Timothy Daly

Enzon Pharmaceuticals

Chief Accounting Officer

You may also like